Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

G1 Therapeutics, Inc. (GTHX)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
 
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Net income  -147.6-148.4-99.3-122.4-85.3-64.9-34.7-21.7
Depreciation and amortization  0.50.50.60.40.20.10.10.0
Stock-based compensation  20.622.318.816.410.23.41.40.4
Change in working capital   [+]31.218.819.76.10.66.13.67.1
Other operating activities  -33.3-25.3-23.5 0.04.84.50.4
Cash from operations  -128.6-132.1-83.7-99.6-74.3-50.5-25.1-13.8
   
Capital expenditures   [+]-0.50.00.0-2.7-0.7-0.3-0.3-0.1
Purchases of short-term investments, net  -50.0       
Cash from investing  -50.50.00.2-2.7-0.7-0.3-0.3-0.1
   
Issuance of common stock, net  52.486.4  339.6108.5  
Option exercises  0.25.82.32.71.80.20.00.1
Financing costs   -1.4-0.6     
Other cash from financing  0.363.923.45.42.7-1.049.833.2
Cash from financing  52.5145.921.72.7340.5107.349.833.2
   
Free cash flow  -129.1-132.1-83.7-102.3-75.0-50.8-25.4-13.9
        Per share (diluted)  ($2.96)($3.15)($2.21)($2.73)($2.25)($2.79)($17.08)($10.36)
   
Cash paid for interest  7.92.91.0     

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy